16S rRNA mutation associated with tetracycline resistance in a gram-positive bacterium

Antimicrob Agents Chemother. 1998 Jul;42(7):1702-5. doi: 10.1128/AAC.42.7.1702.

Abstract

A genetic basis for tetracycline resistance in cutaneous propionibacteria was suggested by comparing the nucleotide sequences of the 16S rRNA genes from 16 susceptible and 21 resistant clinical isolates and 6 laboratory-selected tetracycline-resistant mutants of a susceptible strain. Fifteen clinical isolates resistant to tetracycline were found to have cytosine instead of guanine at a position cognate with Escherichia coli 16S rRNA base 1058 in a region important for peptide chain termination and translational accuracy known as helix 34. Cytosine at base 1058 was not detected in the laboratory mutants or the tetracycline-susceptible strains. The apparent mutation was recreated by site-directed mutagenesis in the cloned E. coli ribosomal operon, rrnB, encoded by pKK3535.E. coli strains carrying the mutant plasmid were more resistant to tetracycline than those carrying the wild-type plasmid both in MIC determinations and when grown in tetracycline-containing liquid medium. These data are consistent with a role for the single 16S rRNA base mutation in clinical tetracycline resistance in cutaneous propionibacteria.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • DNA, Bacterial
  • Escherichia coli / genetics
  • Gram-Positive Bacteria / drug effects
  • Gram-Positive Bacteria / genetics*
  • Microbial Sensitivity Tests
  • Mutagenesis, Site-Directed
  • Plasmids / genetics
  • Propionibacterium / genetics
  • RNA, Ribosomal, 16S / genetics*
  • Tetracycline Resistance / genetics*

Substances

  • DNA, Bacterial
  • RNA, Ribosomal, 16S